Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s DiseaseRobert Martone, J. Steven Jacobsen, Scott C. Mayer et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 157
Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascadeJ. Steven Jacobsen, Menelas N. Pangalos, Thomas A. Comery et al.|Proceedings of the National Academy of Sciences|2008Cited by 141
O3‐06‐07: GSI‐953 is a potent APP‐selective gamma‐secretase inhibitor for the treatment of Alzheimer's diseaseSteven J. Jacobsen, Robert Martone, Thomas A. Comery et al.|Alzheimer s & Dementia|2009Cited by 12
P2‐481: Small molecule BACE‐1 inhibitors are potent, selective and orally activeMichael S. Malamas, Jonathan Bard, Jim Erdei et al.|Alzheimer s & Dementia|2008Cited by 2
P3‐296: BACE1 is not the rate‐limiting enzyme in Aβ production in the brains of APPswe transgenic mice: Pharmacological characterization of BACE1 using novel brain penetrant inhibitors.David Riddell, Peter H. Reinhart, Kevin Atchison et al.|Alzheimer s & Dementia|2009Cited by 1